Nafamostat mesylate

TargetMol
Product Code: TAR-T2392
Supplier: TargetMol
CodeSizePrice
TAR-T2392-10mg10mg£103.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2392-1mL1 mL * 10 mM (in DMSO)£107.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2392-25mg25mg£121.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2392-50mg50mg£145.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2392-100mg100mg£179.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2392-500mg500mg£351.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Nafamostat mesylate, a synthetic serine protease inhibitor, has been used for the treatment of allergic disorders such as asthma, allergic rhinitis and atopic dermatitis.
CAS:
82956-11-4
Formula:
C21H25N5O8S2
Molecular Weight:
539.58
Pathway:
Metabolism; Cell Cycle/Checkpoint; Proteases/Proteasome; Apoptosis; Microbiology/Virology
Purity:
0.9976
SMILES:
CS(O)(=O)=O.CS(O)(=O)=O.NC(=N)Nc1ccc(cc1)C(=O)Oc1ccc2cc(ccc2c1)C(N)=N
Target:
Apoptosis; Serine/threonin kinase; SARS-CoV; Serine Protease

References

1. Sundaram S, et al. Thromb Haemost, 1996, 75(1), 76-82. 2. Uchiba M, et al. Thromb Res, 1994, 74(2), 155-161. 3. Ugawa S, et al. Biochem Biophys Res Commun, 2007, 363(1), 203-208. 4. Ui H, et al. Eur J Pharmacol, 2006, 530(1-2), 172-178. 5. Uwagawa T, et al. Anticancer Res, 2009, 29(8), 3173-3178. 6. Homma S, et al. Nafamostat mesilate, a serine protease inhibitor, suppresses interferon-gamma-induced up-regulation of programmed cell death ligand 1 in human cancer cells. Int Immunopharmacol. 2018 Jan;54:39-45.